Telephone sharing button Contact Us linkedin sharing button LinkedIn mailbox sharing button wuxixdc_info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

About Us

Our Company

Your Single Source for Bioconjugation Discovery, Development and cGMP Manufacturing
WuXi XDC (stock code:2268.HK), a leading Contract Research, Development and Manufacturing Organization (CRDMO) focused on the global ADC and broader bioconjugate market, is a pioneering CRDMO offering integrated, end-to-end services. Services are provided from proximately located, state-of-the-art laboratories and manufacturing facilities, allowing for a significant reduction in development timelines and costs. Our over 1000 skilled employees work across a global network to deliver expert-driven, high-quality and right-first-time project execution for our customers. By offering a single-source, open-access platform with the most comprehensive capabilities and technologies, WuXi XDC enables our biopharmaceutical partners to speed the development of innovative therapies for the benefit of patients worldwide.

 

>
300

Clients worldwide

>
100

Ongoing, integrated CMC development programs*

>
20

Ongoing late-stage, integrated (Phase II / III) programs*

>
50

Successful INDs filed by our clients, enabled through WuXi XDC services

*Integrated programs comprise product development and manufacturing programs contracted to us by our clients that utilize multiple WuXi XDC development capabilities / technologies or services (e.g., cell line development, process development, analytical development, formulation and drug product development etc.) and GMP manufacturing (drug substance, drug product or both)

Vision
& Mission

Our Vision

“Linking innovation to health” by offering an open-access platform with the most comprehensive capabilities and technologies in the global ADC (antibody drug conjugate) and XDC (other novel bioconjugate) industry.

 

Our Mission

To continuously enhance our platform, propel and transform the development of the bioconjugate industry, enable global biopharmaceutical partners and benefit patients worldwide.

 

PROUD Culture

Our PROUD (Passion, Reward, Ownership, Unity, Determination) values and spirit are the driving force behind our actions and activities at WuXi XDC. Come join us to embrace new opportunities and challenges and to help us achieve our vision!
  • P: Passion

    Customer focus
    Positive attitude and energy
    Continuous learning

  • R: Reward

    Tackling tough tasks
    Embracing change
    Giving back to society

  • O: Ownership

    Accountability
    Excellence and efficiency
    Honesty and Ethics

  • U: Unity

    Diversity and inclusion
    Respect and communication
    Teamwork

  • D: Determination

    Strong execution
    GROWTH mindset
    Calculated risks

History

Corporate Development Footprint

  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2016
  • 2013

Business Ethics

As a leading global open-access biologics technology platform, WuXi XDC is committed to the highest standards of ethics and integrity. We strive to deal honestly, ethically and fairly with our customers, suppliers, employees, competitors, and the communities we serve worldwide. WuXi XDC does not engage in false, misleading, deceptive or fraudulent statements for our products and services. We are dedicated to conducting business only with individuals and organizations who share our commitment to the highest ethical standards and operate in a socially and environmentally responsible manner.

In line with that commitment, the Company expects and encourages its employees, customers, suppliers and other stakeholders who have concerns about any suspected misconduct or malpractice within the Company to come forward and voice those concerns through the whistleblowing channel.

Compliance reporting: IA_biologics@wuxibiologics.com, Compliance_Biologics@wuxibiologics.com

WuXi XDC, as a subsidiary of WuXi Biologics, adheres to all business ethics, code of conduct and IP policies as established by WuXi Biologics.

Preservation of your IP is our highest priority.
We have established stringent policies and procedures for IP protection and prosecution of IP violations to ensure your success and win your trust.

Our purpose in business is to enable innovation for our global partners, who keep us at the top of their confidence. IP is our shared lifeline. We guard it at WuXi Biologics with our founding principles of integrity, world-class security, zero tolerance policies, and relentless pursuit of justice against any criminal act. This is our highest priority, and we must hold ourselves accountable. We are determined to earn the trust of our partners by committing to success together.

Intellectual Property Protection is the foundation of trust between WuXi XDC and our global customers. To that end, we have established the most stringent policies in China and in U.S. for the protection of intellectual property and for avoidance of IP violations which is aligned to the industry-leading rigorous IP protection policies of WuXi Biologics. Our purpose in business is to enable innovation for our global partners, who keep us at the top of their confidence. We guard IP protection with our founding principles of integrity, world-class security, zero-tolerance policies, and relentless pursuit of justice against any criminal act.

Environmental Social Governance (ESG)

We are dedicated to implementing sustainable and eco-friendly business practices by building a comprehensive and integrated Environmental, Health and Safety (EHS) management system, sourcing ethically, reducing our environmental footprint, advocating reduced energy consumption, minimizing effluent, and acting responsibly to reduce operational impact on the environment.

On our Diversity, Equity and Inclusion initiatives, we strive to advance a diverse workforce and create an equal and inclusive corporate culture. To this end, we recruit employees based on their professional and academic achievements regardless of religion, disability, age, race, color, sex, gender identity, sexual orientation, or marital status to provide equal employment opportunity.

Along with the creation of our own compliance management system and ethical standards training programs for all employees, our “Zero tolerance” for bribery and corruption principles along with our commitment to honesty and trustworthy business conduct promote our ESG culture.

The WuXi XDC ESG report can be found here.

Notice:

You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?